Salix Pharmaceuticals, Ltd. Release: Colazal® Food Effect Application Granted FDA Approval

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announces that the U.S. Food and Drug Administration approved a supplemental new drug application which provides for changes to the approved labeling for COLAZAL® based upon the pharmacokinetics of COLAZAL administered with food as well as sprinkled over food.

>>> Discuss This Story

Back to news